SQZ Biotechnologies Co
SQZDelisted Jul 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604477
SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by SQZ Biotechnologies Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for SQZ Biotechnologies Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Schulman Amy W | Director, 10% Owner | 214,814 | Jun 15, 2023 | 0 |
| Vink Patrick V.J.J. | Director | – | Jun 15, 2023 | 0 |
| Srivastava Sapna | Director | – | Jun 15, 2023 | 0 |
| Bolno Paul | Director | – | Jun 15, 2023 | 0 |
| Schegerin Marc | Director | – | Jun 15, 2023 | 0 |
| Coulie Bernard | Director | – | Jun 15, 2023 | 0 |
| Garg Pushkal | Director | – | Jun 15, 2023 | 0 |
| Jensen Klavs F. | Director | 353,309 | Jun 15, 2023 | 0 |
| Elia Marc | Director | – | Jun 15, 2023 | 0 |
| Bernstein Howard PhD MD | Interim Chief Executive Office | – | Jan 26, 2023 | 0 |
| Knopf Lawrence J | General Counsel | 1,938 | Jan 26, 2023 | 0 |
| First David | Chief People Officer | – | Jan 26, 2023 | 0 |
| Capasso Richard | See Remarks | 0 | Jan 26, 2023 | 0 |
| Warren Marshelle Smith | Chief Medical Officer | – | Jan 26, 2023 | 0 |
| Zajic Micah | Chief Financial Officer | – | Jul 13, 2022 | 0 |
| Sharei Armon | President and CEO | 287,884 | Jul 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Schulman Amy WDirector, 10% Owner | PPurchase | +3.70K | $10.91 | +$40.4K | New position1.85K after | 2 lots |
| May 27, 2022 (view filing) | May 25 | 2 days | Jensen Klavs F.Director | PPurchase | +14.3K | $3.52 | +$50.4K | +4.2%353.3K after | |
| Aug 16, 2022 (view filing) | Aug 15 | 1 day | Capasso RichardSee Remarks | SSale | −1.18K | $3.33 | −$3.94K | −100.0%0 after |